0001539007-18-000002.txt : 20181023
0001539007-18-000002.hdr.sgml : 20181023
20181022190309
ACCESSION NUMBER: 0001539007-18-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20181023
DATE AS OF CHANGE: 20181022
EFFECTIVENESS DATE: 20181023
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alafair Biosciences, Inc.
CENTRAL INDEX KEY: 0001539007
IRS NUMBER: 274833315
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-324080
FILM NUMBER: 181133047
BUSINESS ADDRESS:
STREET 1: 6101 W. COURTYARD DRIVE
STREET 2: SUITE 2-225
CITY: AUSTIN
STATE: TX
ZIP: 78730
BUSINESS PHONE: 512-739-9510
MAIL ADDRESS:
STREET 1: 6101 W. COURTYARD DRIVE
STREET 2: SUITE 2-225
CITY: AUSTIN
STATE: TX
ZIP: 78730
D
1
primary_doc.xml
X0708
D
LIVE
0001539007
Alafair Biosciences, Inc.
6101 W. COURTYARD DRIVE
SUITE 2-225
AUSTIN
TX
TEXAS
78730
512-739-9510
DELAWARE
Alafair Biotechnology, Inc.
None
Corporation
true
R.
Gregory
Brophy
6101 W. Courtyard Drive
Suite 2-225
Austin
TX
TEXAS
78730
Executive Officer
Daniel
Peterson
6101 W. Courtyard Drive
Suite 2-225
Austin
TX
TEXAS
78730
Director
John
Joyoprayitno
6101 W. Courtyard Drive
Suite 2-225
Austin
TX
TEXAS
78730
Executive Officer
Jerry
DeVries
6101 W. Courtyard Drive
Suite 2-225
Austin
TX
TEXAS
78730
Director
James
Patrick
Feller
6101 Courtyard Drive
Suite 2-225
Austin
TX
TEXAS
78730
Director
John
B.
Henneman
6101 Courtyard Drive
Suite 2-225
Austin
TX
TEXAS
78730
Director
Kyle
A.
Cox
6101 Courtyard Drive
Suite 2-225
Austin
TX
TEXAS
78730
Director
Mark
Benedyk
6101 W. Courtyard Drive
Suite 2-225
Austin
TX
TEXAS
78730
Director
Biotechnology
Decline to Disclose
- 06b
false
2018-09-28
false
true
false
0
6830168
2330168
4500000
The Total Offering Amount and Total Amount Sold include an aggregate amount of $1,830,168 from convertible notes (reported on the Issuer's Form D filed 7-19-2017) that automatically converted into equity of the Issuer.
false
15
0
0
0
false
Alafair Biosciences, Inc.
R. Gregory Brophy
R. Gregory Brophy
CEO and President
2018-10-19